US5656290A
(en)
*
|
1993-02-26 |
1997-08-12 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
US5965161A
(en)
†
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
DE19531277A1
(de)
*
|
1995-08-25 |
1997-02-27 |
Basf Ag |
Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
|
DE19539360A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
DE19539362A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
FR2748209B1
(fr)
*
|
1996-05-06 |
1998-06-05 |
Adir |
Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs
|
DE19637082A1
(de)
|
1996-09-12 |
1998-03-19 |
Boehringer Mannheim Gmbh |
Schnellzerfallende Pellets
|
US8828432B2
(en)
*
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
FR2761605B1
(fr)
*
|
1997-04-07 |
2001-02-23 |
Prographarm Lab |
Forme pharmaceutique multiparticulaire, ses particules constitutives, procede et installation pour leur fabrication
|
EP1065936B1
(en)
*
|
1998-03-23 |
2009-08-05 |
General Mills, Inc. |
Encapsulation of components into edible products
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
CZ2002336A3
(cs)
|
1999-07-30 |
2002-06-12 |
Smithkline Beecham Plc |
Multikomponentní farmaceutická dávková forma
|
DE10045904B4
(de)
*
|
1999-10-01 |
2007-07-12 |
Degussa Gmbh |
alpha-Liponsäure(-Derivate) enthaltende Retardform
|
RU2230556C2
(ru)
|
1999-10-29 |
2004-06-20 |
Эро-Селтик, С.А. |
Препаративные формы гидрокодона с контролируемым высвобождением
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
US7364752B1
(en)
|
1999-11-12 |
2008-04-29 |
Abbott Laboratories |
Solid dispersion pharamaceutical formulations
|
WO2001034119A2
(en)
*
|
1999-11-12 |
2001-05-17 |
Abbott Laboratories |
Inhibitors of crystallization in a solid dispersion
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
EP1272181A2
(en)
*
|
2000-04-13 |
2003-01-08 |
Synthon B.V. |
Modified release formulations containing a hypnotic agent
|
DE10026698A1
(de)
*
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
AU2002227383B2
(en)
|
2000-10-30 |
2004-07-08 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
US7842308B2
(en)
*
|
2001-01-30 |
2010-11-30 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
GB0102342D0
(en)
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US7883721B2
(en)
|
2001-01-30 |
2011-02-08 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
US6555581B1
(en)
|
2001-02-15 |
2003-04-29 |
Jones Pharma, Inc. |
Levothyroxine compositions and methods
|
US20030198671A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique plasma AUC properties
|
DE10150938A1
(de)
*
|
2001-10-04 |
2003-04-24 |
Frunol Delicia Gmbh |
Schädlingsbekämpfungsmittel und Verfahren zu dessen Herstellung
|
US20030165564A1
(en)
*
|
2001-10-29 |
2003-09-04 |
Franz G. Andrew |
Levothyroxine compositions having unique triiodothyronine Tmax properties
|
US7700134B2
(en)
*
|
2002-01-17 |
2010-04-20 |
The Regents Of The University Of Michigan |
Prevention of cisplatin induced deafness
|
US20050182056A9
(en)
*
|
2002-02-21 |
2005-08-18 |
Seth Pawan |
Modified release formulations of at least one form of tramadol
|
US8128957B1
(en)
|
2002-02-21 |
2012-03-06 |
Valeant International (Barbados) Srl |
Modified release compositions of at least one form of tramadol
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
EP1519704A2
(en)
*
|
2002-06-27 |
2005-04-06 |
Cilag AG |
Spherical pellet containing a water-soluble active ingredient
|
US8840928B2
(en)
|
2002-07-05 |
2014-09-23 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US7399488B2
(en)
*
|
2002-07-05 |
2008-07-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
US10004729B2
(en)
|
2002-07-05 |
2018-06-26 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2004014318A2
(en)
*
|
2002-08-10 |
2004-02-19 |
King Pharmaceuticals, Inc. |
Levothyroxine compositions and methods
|
DE10247037A1
(de)
*
|
2002-10-09 |
2004-04-22 |
Abbott Gmbh & Co. Kg |
Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
|
KR20040043589A
(ko)
*
|
2002-11-19 |
2004-05-24 |
경동제약 주식회사 |
서방성 세파클러 제제 및 그 제조방법
|
SI21353A
(sl)
*
|
2002-11-27 |
2004-06-30 |
Lek farmacevtska družba, d.d. |
Pelete vsebujoče brezvodne tekočine in proces njihove priprave
|
ES2208124B1
(es)
*
|
2002-11-29 |
2005-10-01 |
Laboratorios Del Dr. Esteve, S.A. |
Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
|
ES2208123A1
(es)
*
|
2002-11-29 |
2004-06-01 |
Laboratorios Del Dr. Esteve, S.A. |
Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
|
EP1590144B1
(en)
*
|
2002-12-10 |
2015-07-29 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
CN100500130C
(zh)
*
|
2003-01-23 |
2009-06-17 |
株式会社太平洋 |
缓释制剂及其制备方法
|
US20070059358A1
(en)
*
|
2003-07-02 |
2007-03-15 |
Tianjin Tasly Pharmaceutical Co., Ltd., China |
Matrix adjuvants and the drop pills prepared with them
|
TW200526274A
(en)
|
2003-07-21 |
2005-08-16 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
TWI350762B
(en)
*
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
GB0403098D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
TW201240679A
(en)
|
2004-03-12 |
2012-10-16 |
Capsugel Belgium Nv |
Pharmaceutical formulations
|
PT1765292T
(pt)
|
2004-06-12 |
2017-12-29 |
Collegium Pharmaceutical Inc |
Formulações de fármacos dissuasoras de abuso
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
CN1988889A
(zh)
*
|
2004-07-22 |
2007-06-27 |
株式会社太平洋 |
含托吡酯的缓释制剂及其制备方法
|
JP5078361B2
(ja)
*
|
2004-12-27 |
2012-11-21 |
株式会社カネカ |
熱可塑性樹脂組成物
|
TW200630401A
(en)
*
|
2004-12-27 |
2006-09-01 |
Kaneka Corp |
Process for producing aggregated latex particle
|
US20080108750A1
(en)
*
|
2004-12-27 |
2008-05-08 |
Toru Terada |
Thermoplastic Resin Composition
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US7803413B2
(en)
*
|
2005-10-31 |
2010-09-28 |
General Mills Ip Holdings Ii, Llc. |
Encapsulation of readily oxidizable components
|
US20070184163A1
(en)
*
|
2006-02-07 |
2007-08-09 |
International Flavors, & Fragrances Inc. |
Non-hygroscopic flavor particles
|
JP5826456B2
(ja)
*
|
2006-04-26 |
2015-12-02 |
アルファファーム ピーティーワイ リミテッド |
コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
JP5452236B2
(ja)
*
|
2007-03-02 |
2014-03-26 |
ファーナム・カンパニーズ・インコーポレーテッド |
ロウ様物質を用いた徐放性組成物
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
JP2011503048A
(ja)
|
2007-11-08 |
2011-01-27 |
グラクソ グループ リミテッド |
医薬製剤
|
WO2009088318A1
(ru)
*
|
2007-12-29 |
2009-07-16 |
Physics Depertment M.V. Lomonosov Moscow State University |
Магнитные полимерные гранулы и способы их применения
|
WO2009088319A1
(ru)
*
|
2007-12-29 |
2009-07-16 |
Physics Depertment M.V. Lomonosov Moscow State University |
Магнитные полимерные гранулы и способ формирования блокирующей гелевой пробки
|
EP2249811A1
(en)
|
2008-01-25 |
2010-11-17 |
Grünenthal GmbH |
Pharmaceutical dosage form
|
KR101094231B1
(ko)
*
|
2008-02-18 |
2011-12-14 |
하나제약 주식회사 |
서방성 고형 제제 및 그의 제조방법
|
EP2273983B1
(en)
|
2008-05-09 |
2016-07-20 |
Grünenthal GmbH |
Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
|
MX2011000825A
(es)
*
|
2008-07-22 |
2011-02-25 |
Gen Mills Inc |
Productos frutales que contienen acidos grasos omega-3.
|
WO2010141821A1
(en)
*
|
2009-06-05 |
2010-12-09 |
General Mills, Inc. |
Encapsulated omega-3 fatty acids for baked goods production
|
PL2456424T3
(pl)
|
2009-07-22 |
2013-12-31 |
Gruenenthal Gmbh |
Stabilizowana przed utlenianiem odporna na naruszenie postać dawkowania
|
PL2456427T3
(pl)
|
2009-07-22 |
2015-07-31 |
Gruenenthal Gmbh |
Wytłaczana na gorąco postać dawki o kontrolowanym uwalnianiu
|
BR112012013487A2
(pt)
|
2009-12-02 |
2017-10-03 |
Adamas Pharmaceuticals Inc |
Composições de amantadina e métodos de uso
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
JP2013526523A
(ja)
|
2010-05-11 |
2013-06-24 |
シマ ラブス インク. |
メトプロロールを含むアルコール耐性持続放出性経口剤形
|
AU2011297901B2
(en)
|
2010-09-02 |
2014-07-31 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
MX2013002293A
(es)
|
2010-09-02 |
2013-05-09 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
|
DE102011018403A1
(de)
*
|
2011-04-21 |
2012-10-25 |
Automatik Plastics Machinery Gmbh |
Verfahren zur Herstellung von pharmazeutischen Erzeugnissen aus einem Schmelzematerial
|
US20130028972A1
(en)
|
2011-07-29 |
2013-01-31 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
PE20141638A1
(es)
|
2011-07-29 |
2014-11-22 |
Gruenenthal Chemie |
Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
|
US20130225697A1
(en)
|
2012-02-28 |
2013-08-29 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
EA201401139A1
(ru)
|
2012-04-18 |
2015-03-31 |
Грюненталь Гмбх |
Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
JP6445537B2
(ja)
|
2013-05-29 |
2018-12-26 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
RU2535049C1
(ru)
*
|
2013-07-11 |
2014-12-10 |
Общество с ограниченной ответственностью "КОМПАНИЯ "ДЕКО" |
Способ получения стабилизированной субстанции дротаверина гидрохлорида
|
JP6449871B2
(ja)
|
2013-07-12 |
2019-01-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エチレン−酢酸ビニルポリマーを含有する改変防止剤形
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
JP6480936B2
(ja)
|
2013-11-26 |
2019-03-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
クライオミリングによる粉末状医薬組成物の調製
|
WO2015173195A1
(en)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
EP3148512A1
(en)
|
2014-05-26 |
2017-04-05 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
WO2016170097A1
(en)
|
2015-04-24 |
2016-10-27 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
BR112020003375A2
(pt)
|
2017-08-24 |
2020-08-25 |
Adamas Pharma, Llc |
composições de amantadina, preparações das mesmas, e métodos de uso
|
US20220062200A1
(en)
|
2019-05-07 |
2022-03-03 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
WO2020225773A1
(en)
|
2019-05-07 |
2020-11-12 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|